FI955316A0 - Amindderivat av vitamin D - Google Patents

Amindderivat av vitamin D

Info

Publication number
FI955316A0
FI955316A0 FI955316A FI955316A FI955316A0 FI 955316 A0 FI955316 A0 FI 955316A0 FI 955316 A FI955316 A FI 955316A FI 955316 A FI955316 A FI 955316A FI 955316 A0 FI955316 A0 FI 955316A0
Authority
FI
Finland
Prior art keywords
group
pct
alpha
vitamin
sec
Prior art date
Application number
FI955316A
Other languages
English (en)
Finnish (fi)
Other versions
FI955316A (sv
FI112361B (sv
Inventor
Robert Henry Hesse
Sundara Katugam Srinivas Setty
Malathi Ramgopal
Original Assignee
Res Inst Medicine Chem
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Res Inst Medicine Chem filed Critical Res Inst Medicine Chem
Publication of FI955316A0 publication Critical patent/FI955316A0/sv
Publication of FI955316A publication Critical patent/FI955316A/sv
Application granted granted Critical
Publication of FI112361B publication Critical patent/FI112361B/sv

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D295/00—Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms
    • C07D295/16—Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms acylated on ring nitrogen atoms
    • C07D295/18—Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms acylated on ring nitrogen atoms by radicals derived from carboxylic acids, or sulfur or nitrogen analogues thereof
    • C07D295/182—Radicals derived from carboxylic acids
    • C07D295/185—Radicals derived from carboxylic acids from aliphatic carboxylic acids
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00—Drugs for disorders of the respiratory system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P5/00—Drugs for disorders of the endocrine system
    • A61P5/10—Drugs for disorders of the endocrine system of the posterior pituitary hormones, e.g. oxytocin, ADH
    • A61P5/12—Drugs for disorders of the endocrine system of the posterior pituitary hormones, e.g. oxytocin, ADH for decreasing, blocking or antagonising the activity of the posterior pituitary hormones
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/02—Non-specific cardiovascular stimulants, e.g. drugs for syncope, antihypotensives
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C401/00—Irradiation products of cholesterol or its derivatives; Vitamin D derivatives, 9,10-seco cyclopenta[a]phenanthrene or analogues obtained by chemical preparation without irradiation
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D295/00—Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms
    • C07D295/16—Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms acylated on ring nitrogen atoms
    • C07D295/20—Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms acylated on ring nitrogen atoms by radicals derived from carbonic acid, or sulfur or nitrogen analogues thereof
    • C07D295/215—Radicals derived from nitrogen analogues of carbonic acid

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Cardiology (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Pain & Pain Management (AREA)
  • Diabetes (AREA)
  • Endocrinology (AREA)
  • Communicable Diseases (AREA)
  • Oncology (AREA)
  • Immunology (AREA)
  • Rheumatology (AREA)
  • Pulmonology (AREA)
  • Dermatology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Saccharide Compounds (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
FI955316A 1993-05-07 1995-11-06 Förfarande för framställning av terapeutiskt användbara derivat av vitamin D FI112361B (sv)

Applications Claiming Priority (4)

Application Number Priority Date Filing Date Title
GB9309422 1993-05-07
GB939309422A GB9309422D0 (en) 1993-05-07 1993-05-07 Chemical compounds
PCT/GB1994/000975 WO1994026707A1 (en) 1993-05-07 1994-05-06 Vitamin d amide derivatives
GB9400975 1994-05-06

Publications (3)

Publication Number Publication Date
FI955316A0 true FI955316A0 (sv) 1995-11-06
FI955316A FI955316A (sv) 1995-12-22
FI112361B FI112361B (sv) 2003-11-28

Family

ID=10735089

Family Applications (1)

Application Number Title Priority Date Filing Date
FI955316A FI112361B (sv) 1993-05-07 1995-11-06 Förfarande för framställning av terapeutiskt användbara derivat av vitamin D

Country Status (20)

Country Link
US (1) US5756733A (sv)
EP (1) EP0696275B1 (sv)
JP (1) JP3703099B2 (sv)
KR (1) KR100321414B1 (sv)
CN (1) CN1093852C (sv)
AT (1) ATE169617T1 (sv)
AU (1) AU678246B2 (sv)
CA (1) CA2162272A1 (sv)
CZ (1) CZ291238B6 (sv)
DE (1) DE69412476T2 (sv)
DK (1) DK0696275T3 (sv)
ES (1) ES2122275T3 (sv)
FI (1) FI112361B (sv)
GB (1) GB9309422D0 (sv)
HU (1) HUT74165A (sv)
IL (1) IL109595A (sv)
NO (1) NO309187B1 (sv)
NZ (1) NZ265665A (sv)
WO (1) WO1994026707A1 (sv)
ZA (1) ZA943162B (sv)

Families Citing this family (26)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB9405715D0 (en) * 1994-03-23 1994-05-11 Res Inst Medicine Chem Chemical compounds
CA2342471C (en) * 1995-06-06 2002-10-29 Judith L. Treadway Heterocyclecarbonylmethyl amine intermediates
DE19619036A1 (de) 1996-04-30 1997-11-13 Schering Ag Neue Vitamin D-Derivate mit carbo- oder heterocyclischen Substituenten an C-25, Verfahren zu ihrer Herstellung und die Verwendung zur Herstellung von Arzneimitteln
GB9623569D0 (en) * 1996-11-13 1997-01-08 Immunodiagnostic Systems Ltd Vitamin D immumoassay systems
US6043385A (en) * 1997-12-16 2000-03-28 Hoffman-La Roche Inc. Vitamin D derivatives
GB9804861D0 (en) * 1998-03-06 1998-04-29 Res Inst Medicine Chem Chemical compounds
WO2000024712A1 (fr) * 1998-10-23 2000-05-04 Teijin Limited Derives de vitamine d3 et medicaments contre des maladies respiratoires inflammatoires les contenant
DK1666026T4 (da) * 1999-02-08 2015-05-04 Intarcia Therapeutics Inc Ikke-vandige enkelt-fase biokompatible, viskøse fremføringsmidler og fremgangsmåder til fremstilling deraf
DE19935771A1 (de) * 1999-07-23 2001-02-01 Schering Ag Neue Vitamin D-Derivate mit cyclischen Substrukturen in den Seitenketten, Verfahren und Zwischenprodukte zu ihrer Herstellung und die Verwendung zur Herstellung von Arzneimitteln
DE60019947T2 (de) 1999-09-29 2006-02-02 Colotech A/S Prävention von kolorektalem Krebs
US6703380B2 (en) 1999-09-29 2004-03-09 Colotech A/S Prevention of cancer
US6989377B2 (en) 1999-12-21 2006-01-24 Wisconsin Alumni Research Foundation Treating vitamin D responsive diseases
US6358939B1 (en) 1999-12-21 2002-03-19 Northern Lights Pharmaceuticals, Llc Use of biologically active vitamin D compounds for the prevention and treatment of inflammatory bowel disease
TWI288131B (en) * 2000-06-15 2007-10-11 Chugai Pharmaceutical Co Ltd Vitamin D derivative, compounds pharmaceutical composition thereof
ES2364623T3 (es) * 2000-06-15 2011-09-08 Chugai Seiyaku Kabushiki Kaisha Derivados de vitamina d que poseen un átomo 22-oxa o 22-tia, una cadena lateral c17 sustituida con un grupo ácido, éster o amida y un enlace doble 16(17).
US6277877B1 (en) 2000-08-15 2001-08-21 Pfizer, Inc. Substituted n-(indole-2-carbonyl)glycinamides and derivates as glycogen phosphorylase inhibitors
ES2315494T3 (es) * 2002-04-26 2009-04-01 Schering Corporation Antagonistas muscarinicos.
KR20150140872A (ko) 2006-06-02 2015-12-16 니뽄 신야쿠 가부시키가이샤 9,10-세코프레그난 유도체 및 의약
WO2009117831A1 (en) * 2008-03-27 2009-10-01 The Royal Institution For The Advancement Of Learning/Mcgill University Hybrid molecules having mixed vitamin d receptor agonism and histone deacetylase inhibitory properties
SG173119A1 (en) 2009-01-27 2011-08-29 Berg Biosystems Llc Vitamin d3 and analogs thereof for alleviating side effects associated with chemotherapy
EP3603646B1 (en) 2009-08-14 2024-04-03 BPGbio, Inc. Vitamin d3 and analogs thereof for treating alopecia
US9290447B2 (en) 2011-05-03 2016-03-22 Wisconsin Alumni Research Foundation (20R) and (20S)-24-(p-toluenesulfonyloxy)-25,26,27-trinorvitamin D3 analogs and their uses
WO2012158794A1 (en) 2011-05-17 2012-11-22 Wisconsin Alumni Research Foundation N-cyclopropyl-(20r)-2-methylene-19,26,27-trinor-25-aza-vitamin d analogs and their uses
CN112156097A (zh) 2013-05-29 2021-01-01 博格有限责任公司 使用维生素d预防或减轻化疗诱发的脱发
US9338493B2 (en) 2014-06-30 2016-05-10 Apple Inc. Intelligent automated assistant for TV user interactions
US10548908B2 (en) 2016-09-15 2020-02-04 Nostopharma, LLC Compositions and methods for preventing and treating heterotopic ossification and pathologic calcification

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB8929059D0 (en) * 1989-12-22 1990-02-28 Leo Pharm Prod Ltd Chemical compounds
HU221008B1 (hu) * 1991-11-07 2002-07-29 Research Institute For Medicine And Chemistry D-vitamin-származékok és azokat tartalmazó gyógyászati készítmények

Also Published As

Publication number Publication date
CA2162272A1 (en) 1994-11-24
NZ265665A (en) 1997-05-26
IL109595A0 (en) 1994-08-26
FI955316A (sv) 1995-12-22
CZ290395A3 (en) 1996-06-12
FI112361B (sv) 2003-11-28
CN1125436A (zh) 1996-06-26
NO954426D0 (no) 1995-11-06
ES2122275T3 (es) 1998-12-16
HUT74165A (en) 1996-11-28
AU678246B2 (en) 1997-05-22
NO309187B1 (no) 2000-12-27
GB9309422D0 (en) 1993-06-23
ZA943162B (en) 1995-04-13
CZ291238B6 (cs) 2003-01-15
WO1994026707A1 (en) 1994-11-24
EP0696275B1 (en) 1998-08-12
IL109595A (en) 1999-04-11
DK0696275T3 (da) 1998-11-09
AU6683294A (en) 1994-12-12
CN1093852C (zh) 2002-11-06
DE69412476T2 (de) 1999-03-11
ATE169617T1 (de) 1998-08-15
EP0696275A1 (en) 1996-02-14
US5756733A (en) 1998-05-26
DE69412476D1 (de) 1998-09-17
NO954426L (no) 1996-01-08
JPH08509971A (ja) 1996-10-22
KR100321414B1 (ko) 2002-12-05
JP3703099B2 (ja) 2005-10-05
HU9503190D0 (en) 1996-01-29

Similar Documents

Publication Publication Date Title
FI955316A0 (sv) Amindderivat av vitamin D
DE69414115D1 (de) Vitamin d analoge
DE69208478D1 (de) Amid derivate von vitamin d
FI962440A0 (sv) Vitamin D amin- och amidderivat
NO963949L (no) Amidderivater av vitamin D
BG99688A (en) Insecticide derivatives of 5-substituted-2,4-diaminopyrimidines
DE69122812D1 (de) Glutathionderivat

Legal Events

Date Code Title Description
MA Patent expired